Stock A052260 HYUNDAI BIOLAND CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials HYUNDAI BIOLAND Co.,Ltd.

Equities

A052260

KR7052260007

Personal Products

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
9,110 KRW -.--% Intraday chart for HYUNDAI BIOLAND Co.,Ltd. +2.24% -8.72%
2023 HYUNDAI BIOLAND Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2020 Hyundai HCN Co.,Ltd. completed the acquisition of 27.94% stake in SKbioland Co., Ltd. from SKC Co., Ltd.. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 237,750 315,750 366,750 258,000 201,750 149,700
Enterprise Value (EV) 1 247,656 341,672 398,787 276,570 214,225 159,645
P/E ratio 15.8 x 29.1 x -27.1 x -22.1 x 42.3 x 18.6 x
Yield 1.89% 1.66% 0.41% 0.41% 0.52% -
Capitalization / Revenue 2.36 x 2.97 x 4.13 x 2.51 x 2.03 x 1.47 x
EV / Revenue 2.46 x 3.21 x 4.49 x 2.69 x 2.16 x 1.57 x
EV / EBITDA 10.7 x 16.3 x -138 x 14.4 x 13.9 x 12 x
EV / FCF -60.7 x -24.5 x 83.4 x 18.7 x 111 x -104 x
FCF Yield -1.65% -4.09% 1.2% 5.36% 0.9% -0.96%
Price to Book 1.6 x 2.03 x 2.67 x 2.06 x 1.56 x 1.1 x
Nbr of stocks (in thousands) 15,000 15,000 15,000 15,000 15,000 15,000
Reference price 2 15,850 21,050 24,450 17,200 13,450 9,980
Announcement Date 3/4/19 3/2/20 3/10/21 3/14/22 3/10/23 3/12/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 100,589 106,311 88,899 102,802 99,154 101,691
EBITDA 1 23,240 20,961 -2,886 19,219 15,383 13,349
EBIT 1 17,056 14,460 -8,861 10,658 9,055 7,048
Operating Margin 16.96% 13.6% -9.97% 10.37% 9.13% 6.93%
Earnings before Tax (EBT) 1 16,034 12,995 -17,921 -15,165 6,844 9,992
Net income 1 15,047 10,849 -13,545 -11,686 4,764 8,056
Net margin 14.96% 10.2% -15.24% -11.37% 4.8% 7.92%
EPS 2 1,003 723.3 -903.0 -779.1 317.6 537.0
Free Cash Flow 1 -4,077 -13,967 4,779 14,826 1,937 -1,540
FCF margin -4.05% -13.14% 5.38% 14.42% 1.95% -1.51%
FCF Conversion (EBITDA) - - - 77.14% 12.59% -
FCF Conversion (Net income) - - - - 40.65% -
Dividend per Share 2 300.0 350.0 100.0 70.00 70.00 -
Announcement Date 3/4/19 3/2/20 3/10/21 3/14/22 3/10/23 3/12/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 9,906 25,922 32,037 18,570 12,475 9,945
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.4262 x 1.237 x -11.1 x 0.9662 x 0.811 x 0.745 x
Free Cash Flow 1 -4,077 -13,967 4,779 14,826 1,937 -1,540
ROE (net income / shareholders' equity) 10.5% 7.12% -9.25% -8.9% 3.74% 6.07%
ROA (Net income/ Total Assets) 5.77% 4.49% -2.79% 3.7% 3.24% 2.45%
Assets 1 260,823 241,408 485,133 -316,141 146,843 329,334
Book Value Per Share 2 9,927 10,382 9,149 8,357 8,619 9,060
Cash Flow per Share 2 1,370 954.0 692.0 983.0 510.0 906.0
Capex 1 12,807 15,951 6,041 2,261 3,782 5,767
Capex / Sales 12.73% 15% 6.8% 2.2% 3.81% 5.67%
Announcement Date 3/4/19 3/2/20 3/10/21 3/14/22 3/10/23 3/12/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Cosmetics & Perfumes

1st Jan change Capi.
HYUNDAI BIOLAND CO.,LTD. Stock HYUNDAI BIOLAND Co.,Ltd.
-8.72% 98.75M
L'ORÉAL Stock L'Oréal
-3.10% 251B
KAO CORPORATION Stock Kao Corporation
+12.81% 19.44B
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 17.73B
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
+0.38% 11.04B
COTY INC. Stock Coty Inc.
-6.84% 10.11B
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+16.90% 7.51B
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+10.15% 5.97B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
-1.01% 4.42B
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-17.67% 3.7B
Cosmetics & Perfumes
  1. Stock Market
  2. Equities
  3. A052260 Stock
  4. Financials HYUNDAI BIOLAND Co.,Ltd.